Cervus canadensis isolate Bull #8, Minnesota chromosome 23, ASM1932006v1, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Cervidae; Cervinae; Cervus.
A pseudomolecule assembly of the Rocky Mountain elk genome
REFSEQ INFORMATION: The reference sequence is identical to\nCM033213.1.\nAssembly name: ASM1932006v1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Iowa State University on\n2021/07/26. The original whole-genome shotgun project has the\naccession JACTMD000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Iowa State University\nAssembly Date :: 24-AUG-2020\nAssembly Method :: MaSuRCA v. MAY-2018\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 686.0x\nSequencing Technology :: PacBio RSII; Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Cervus canadensis Annotation Release\n 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
COORDINATES: polyA evidence [ECO:0006239]
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
SET binding protein 1, transcript variant X1
SET binding protein 1, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 24 Proteins, and 12% coverage of the annotated genomic feature by RNAseq alignments
urea transporter 2, transcript variant X2
urea transporter 2, transcript variant X5
urea transporter 2, transcript variant X4
urea transporter 2, transcript variant X3
urea transporter 2, transcript variant X1
solute carrier family 14 member 1 (Kidd blood group), transcript variant X6
solute carrier family 14 member 1 (Kidd blood group), transcript variant X2
solute carrier family 14 member 1 (Kidd blood group), transcript variant X1
solute carrier family 14 member 1 (Kidd blood group), transcript variant X4
solute carrier family 14 member 1 (Kidd blood group), transcript variant X3
solute carrier family 14 member 1 (Kidd blood group), transcript variant X5
solute carrier family 14 member 1 (Kidd blood group), transcript variant X7
solute carrier family 14 member 1 (Kidd blood group), transcript variant X8
sialic acid binding Ig like lectin 15, transcript variant X2
sialic acid binding Ig like lectin 15, transcript variant X1
sialic acid-binding Ig-like lectin 15 isoform X1
sialic acid-binding Ig-like lectin 15 isoform X2
ectopic P-granules autophagy protein 5 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 8% coverage of the annotated genomic feature by RNAseq alignments
phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
proline-serine-threonine phosphatase interacting protein 2
proline-serine-threonine phosphatase-interacting protein 2
cytochrome b-c1 complex subunit 6, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
ATP synthase subunit alpha, mitochondrial
HAUS augmin like complex subunit 1, transcript variant X1
HAUS augmin like complex subunit 1, transcript variant X2
HAUS augmin-like complex subunit 1 isoform X1
HAUS augmin-like complex subunit 1 isoform X2
chromosome 23 C18orf25 homolog, transcript variant X2
chromosome 23 C18orf25 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
chromosome 23 C18orf25 homolog, transcript variant X1
uncharacterized protein C18orf25 homolog isoform X1
uncharacterized protein C18orf25 homolog isoform X2
uncharacterized protein C18orf25 homolog isoform X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00568
ring finger protein 165, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ring finger protein 165, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
E3 ubiquitin-protein ligase RNF165 isoform X1
ring finger protein 165, transcript variant X2
E3 ubiquitin-protein ligase RNF165 isoform X2
E3 ubiquitin-protein ligase RNF165 isoform X3
lipoxygenase homology PLAT domains 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, 4 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
lipoxygenase homology PLAT domains 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, 5 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
lipoxygenase homology PLAT domains 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
lipoxygenase homology PLAT domains 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
lipoxygenase homology domain-containing protein 1 isoform X2
lipoxygenase homology domain-containing protein 1 isoform X1
lipoxygenase homology domain-containing protein 1 isoform X3
lipoxygenase homology domain-containing protein 1 isoform X4
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5, transcript variant X2
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5, transcript variant X1
alpha-2,8-sialyltransferase 8E isoform X2
alpha-2,8-sialyltransferase 8E isoform X1
protein inhibitor of activated STAT 2, transcript variant X8
protein inhibitor of activated STAT 2, transcript variant X1
protein inhibitor of activated STAT 2, transcript variant X4
protein inhibitor of activated STAT 2, transcript variant X2
protein inhibitor of activated STAT 2, transcript variant X3
protein inhibitor of activated STAT 2, transcript variant X5
protein inhibitor of activated STAT 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 2 ESTs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
protein inhibitor of activated STAT 2, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 2 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
protein inhibitor of activated STAT 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
katanin catalytic subunit A1 like 2, transcript variant X1
katanin catalytic subunit A1 like 2, transcript variant X5
katanin catalytic subunit A1 like 2, transcript variant X7
katanin catalytic subunit A1 like 2, transcript variant X2
katanin catalytic subunit A1 like 2, transcript variant X6
katanin catalytic subunit A1 like 2, transcript variant X3
katanin catalytic subunit A1 like 2, transcript variant X4
katanin p60 ATPase-containing subunit A-like 2 isoform X1
katanin p60 ATPase-containing subunit A-like 2 isoform X5
katanin p60 ATPase-containing subunit A-like 2 isoform X7
katanin p60 ATPase-containing subunit A-like 2 isoform X2
katanin p60 ATPase-containing subunit A-like 2 isoform X6
katanin p60 ATPase-containing subunit A-like 2 isoform X3
katanin p60 ATPase-containing subunit A-like 2 isoform X4
haloacid dehalogenase like hydrolase domain containing 2, transcript variant X1
haloacid dehalogenase like hydrolase domain containing 2, transcript variant X2
haloacid dehalogenase like hydrolase domain containing 2, transcript variant X3
haloacid dehalogenase like hydrolase domain containing 2, transcript variant X4
haloacid dehalogenase like hydrolase domain containing 2, transcript variant X5
haloacid dehalogenase like hydrolase domain containing 2, transcript variant X6
haloacid dehalogenase-like hydrolase domain-containing protein 2
immediate early response 3 interacting protein 1
immediate early response 3-interacting protein 1
SKI family transcriptional corepressor 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 2 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
SKI family transcriptional corepressor 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
SKI family transcriptional corepressor 2 isoform X1
SKI family transcriptional corepressor 2 isoform X2
SMAD family member 2, transcript variant X2
SMAD family member 2, transcript variant X1
mothers against decapentaplegic homolog 2
zinc finger and BTB domain containing 7C, transcript variant X6
zinc finger and BTB domain containing 7C, transcript variant X2
zinc finger and BTB domain containing 7C, transcript variant X5
zinc finger and BTB domain containing 7C, transcript variant X1
zinc finger and BTB domain containing 7C, transcript variant X4
zinc finger and BTB domain containing 7C, transcript variant X3
zinc finger and BTB domain-containing protein 7C isoform X4
zinc finger and BTB domain-containing protein 7C isoform X1
zinc finger and BTB domain-containing protein 7C isoform X2
zinc finger and BTB domain-containing protein 7C isoform X3
zinc finger and BTB domain-containing protein 7C isoform X5
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA cysteine (anticodon GCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins
cap binding complex dependent translation initiation factor, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
cap binding complex dependent translation initiation factor, transcript variant X1
cap binding complex dependent translation initiation factor, transcript variant X5
cap binding complex dependent translation initiation factor, transcript variant X4
cap binding complex dependent translation initiation factor, transcript variant X2
transfer RNA glycine (anticodon CCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
cap binding complex dependent translation initiation factor, transcript variant X3
CBP80/20-dependent translation initiation factor isoform X1
CBP80/20-dependent translation initiation factor isoform X2
SMAD family member 7, transcript variant X2
SMAD family member 7, transcript variant X1
mothers against decapentaplegic homolog 7 isoform X2
mothers against decapentaplegic homolog 7 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 2 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
chromosome 23 C18orf32 homolog, transcript variant X3
chromosome 23 C18orf32 homolog, transcript variant X5
chromosome 23 C18orf32 homolog, transcript variant X4
chromosome 23 C18orf32 homolog, transcript variant X6
UPF0729 protein C18orf32 homolog isoform X2
chromosome 23 C18orf32 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
chromosome 23 C18orf32 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
UPF0729 protein C18orf32 homolog isoform X1
60S ribosomal protein L17-like, transcript variant X1
60S ribosomal protein L17-like, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00151
lipase G, endothelial type, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 10 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
lipase G, endothelial type, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 16 ESTs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
leucine-rich repeat-containing protein 28-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 2 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 26% coverage of the annotated genomic feature by RNAseq alignments
acetyl-CoA acyltransferase 2, transcript variant X1
acetyl-CoA acyltransferase 2, transcript variant X4
3-ketoacyl-CoA thiolase, mitochondrial isoform X1
3-ketoacyl-CoA thiolase, mitochondrial isoform X4
acetyl-CoA acyltransferase 2, transcript variant X2
3-ketoacyl-CoA thiolase, mitochondrial isoform X2
acetyl-CoA acyltransferase 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 108 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
3-ketoacyl-CoA thiolase, mitochondrial isoform X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00492
COORDINATES: nucleotide motif:Rfam:12.0:RF00283
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 27% coverage of the annotated genomic feature by RNAseq alignments
methyl-CpG binding domain protein 1, transcript variant X1
methyl-CpG-binding domain protein 1 isoform X1
methyl-CpG binding domain protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 11 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
methyl-CpG-binding domain protein 1 isoform X2
methyl-CpG binding domain protein 1, transcript variant X8
methyl-CpG-binding domain protein 1 isoform X8
methyl-CpG binding domain protein 1, transcript variant X19
methyl-CpG binding domain protein 1, transcript variant X22
methyl-CpG binding domain protein 1, transcript variant X18
methyl-CpG binding domain protein 1, transcript variant X23
methyl-CpG binding domain protein 1, transcript variant X16
methyl-CpG binding domain protein 1, transcript variant X21
methyl-CpG binding domain protein 1, transcript variant X9
methyl-CpG binding domain protein 1, transcript variant X10
methyl-CpG binding domain protein 1, transcript variant X6
methyl-CpG binding domain protein 1, transcript variant X17
methyl-CpG binding domain protein 1, transcript variant X13
methyl-CpG binding domain protein 1, transcript variant X14
methyl-CpG binding domain protein 1, transcript variant X11
methyl-CpG binding domain protein 1, transcript variant X20
methyl-CpG binding domain protein 1, transcript variant X7
methyl-CpG binding domain protein 1, transcript variant X4
methyl-CpG binding domain protein 1, transcript variant X15
methyl-CpG binding domain protein 1, transcript variant X5
methyl-CpG binding domain protein 1, transcript variant X3
methyl-CpG binding domain protein 1, transcript variant X12
methyl-CpG-binding domain protein 1 isoform X19
methyl-CpG-binding domain protein 1 isoform X16
methyl-CpG-binding domain protein 1 isoform X9
methyl-CpG-binding domain protein 1 isoform X6
methyl-CpG-binding domain protein 1 isoform X11
methyl-CpG-binding domain protein 1 isoform X4
methyl-CpG-binding domain protein 1 isoform X3
methyl-CpG-binding domain protein 1 isoform X23
methyl-CpG-binding domain protein 1 isoform X10
methyl-CpG-binding domain protein 1 isoform X14
methyl-CpG-binding domain protein 1 isoform X7
methyl-CpG-binding domain protein 1 isoform X5
methyl-CpG-binding domain protein 1 isoform X22
methyl-CpG-binding domain protein 1 isoform X18
methyl-CpG-binding domain protein 1 isoform X21
methyl-CpG-binding domain protein 1 isoform X17
methyl-CpG-binding domain protein 1 isoform X13
methyl-CpG-binding domain protein 1 isoform X20
methyl-CpG-binding domain protein 1 isoform X15
methyl-CpG-binding domain protein 1 isoform X12
uncharacterized LOC122425593, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC122425593, transcript variant X1
spindle and kinetochore associated complex subunit 1
spindle and kinetochore-associated protein 1
mitogen-activated protein kinase 4, transcript variant X5
mitogen-activated protein kinase 4, transcript variant X2
mitogen-activated protein kinase 4, transcript variant X3
mitogen-activated protein kinase 4, transcript variant X4
mitogen-activated protein kinase 4, transcript variant X1
NAD-dependent malic enzyme, mitochondrial isoform X1
NAD-dependent malic enzyme, mitochondrial isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, and 49% coverage of the annotated genomic feature by RNAseq alignments
SMAD family member 4, transcript variant X3
SMAD family member 4, transcript variant X1
SMAD family member 4, transcript variant X2
mothers against decapentaplegic homolog 4
RNA-binding E3 ubiquitin-protein ligase MEX3C
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 23% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA glutamic acid (anticodon CUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC122425684, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC122425684, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
DCC netrin 1 receptor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
DCC netrin 1 receptor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
DCC netrin 1 receptor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
DCC netrin 1 receptor, transcript variant X4
DCC netrin 1 receptor, transcript variant X5
DCC netrin 1 receptor, transcript variant X6
transfer RNA glutamic acid (anticodon UUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA cysteine (anticodon ACA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
DNA polymerase iota, transcript variant X1
DNA polymerase iota, transcript variant X2
DNA polymerase iota, transcript variant X3
DNA polymerase iota, transcript variant X4
StAR related lipid transfer domain containing 6
chromosome 23 C18orf54 homolog, transcript variant X1
chromosome 23 C18orf54 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
chromosome 23 C18orf54 homolog, transcript variant X2
chromosome 23 C18orf54 homolog, transcript variant X4
lung adenoma susceptibility protein 2 isoform X3
lung adenoma susceptibility protein 2 isoform X2
lung adenoma susceptibility protein 2 isoform X1
lung adenoma susceptibility protein 2 isoform X4
COORDINATES: nucleotide motif:Rfam:12.0:RF00561
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
cell wall protein DAN4-like, transcript variant X1
cell wall protein DAN4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
RAB27B, member RAS oncogene family, transcript variant X3
RAB27B, member RAS oncogene family, transcript variant X2
52 kDa repressor of the inhibitor of the protein kinase-like
RAB27B, member RAS oncogene family, transcript variant X1
coiled-coil domain containing 68, transcript variant X2
coiled-coil domain containing 68, transcript variant X1
coiled-coil domain-containing protein 68
transcription factor 4, transcript variant X6
transcription factor 4, transcript variant X17
transcription factor 4, transcript variant X16
transcription factor 4, transcript variant X26
transcription factor 4, transcript variant X11
transcription factor 4, transcript variant X8
transcription factor 4, transcript variant X12
transcription factor 4, transcript variant X9
transcription factor 4, transcript variant X10
transcription factor 4, transcript variant X7
transcription factor 4, transcript variant X5
transcription factor 4, transcript variant X13
transcription factor 4, transcript variant X14
transcription factor 4, transcript variant X15
transcription factor 4, transcript variant X4
transcription factor 4, transcript variant X1
transcription factor 4, transcript variant X2
transcription factor 4, transcript variant X3
transcription factor 4, transcript variant X19
transcription factor 4, transcript variant X18
transcription factor 4, transcript variant X22
transcription factor 4, transcript variant X27
transcription factor 4, transcript variant X21
transcription factor 4, transcript variant X20
transcription factor 4, transcript variant X23
transcription factor 4, transcript variant X25
transcription factor 4, transcript variant X24
uncharacterized LOC122425860, transcript variant X2
uncharacterized LOC122425860, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 95% coverage of the annotated genomic feature by RNAseq alignments
thioredoxin like 1, transcript variant X5
thioredoxin like 1, transcript variant X4
thioredoxin like 1, transcript variant X2
thioredoxin like 1, transcript variant X1
thioredoxin like 1, transcript variant X3
polyadenylate-binding protein 4-like, transcript variant X1
polyadenylate-binding protein 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
polyadenylate-binding protein 4-like isoform X1
polyadenylate-binding protein 4-like isoform X2
acidic leucine-rich nuclear phosphoprotein 32 family member B-like
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3
sia-alpha-2,3-Gal-beta-1,4-GlcNAc-R:alpha 2,8-sialyltransferase
ferrochelatase, mitochondrial isoform X1
ferrochelatase, mitochondrial isoform X2
asparaginyl-tRNA synthetase 1, transcript variant X2
asparaginyl-tRNA synthetase 1, transcript variant X1
asparagine--tRNA ligase, cytoplasmic isoform X2
asparagine--tRNA ligase, cytoplasmic isoform X1
transfer RNA serine (anticodon GCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
ATPase phospholipid transporting 8B1, transcript variant X2
ATPase phospholipid transporting 8B1, transcript variant X3
ATPase phospholipid transporting 8B1, transcript variant X1
ATPase phospholipid transporting 8B1, transcript variant X4
phospholipid-transporting ATPase IC isoform X1
phospholipid-transporting ATPase IC isoform X2
transfer RNA glycine (anticodon UCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
NEDD4 like E3 ubiquitin protein ligase, transcript variant X10
NEDD4 like E3 ubiquitin protein ligase, transcript variant X11
NEDD4 like E3 ubiquitin protein ligase, transcript variant X9
NEDD4 like E3 ubiquitin protein ligase, transcript variant X12
E3 ubiquitin-protein ligase NEDD4-like isoform X9
E3 ubiquitin-protein ligase NEDD4-like isoform X12
NEDD4 like E3 ubiquitin protein ligase, transcript variant X13
NEDD4 like E3 ubiquitin protein ligase, transcript variant X1
NEDD4 like E3 ubiquitin protein ligase, transcript variant X5
NEDD4 like E3 ubiquitin protein ligase, transcript variant X7
NEDD4 like E3 ubiquitin protein ligase, transcript variant X2
NEDD4 like E3 ubiquitin protein ligase, transcript variant X3
NEDD4 like E3 ubiquitin protein ligase, transcript variant X6
NEDD4 like E3 ubiquitin protein ligase, transcript variant X8
NEDD4 like E3 ubiquitin protein ligase, transcript variant X4
E3 ubiquitin-protein ligase NEDD4-like isoform X1
E3 ubiquitin-protein ligase NEDD4-like isoform X2
E3 ubiquitin-protein ligase NEDD4-like isoform X3
E3 ubiquitin-protein ligase NEDD4-like isoform X4
E3 ubiquitin-protein ligase NEDD4-like isoform X5
E3 ubiquitin-protein ligase NEDD4-like isoform X6
E3 ubiquitin-protein ligase NEDD4-like isoform X7
E3 ubiquitin-protein ligase NEDD4-like isoform X8
E3 ubiquitin-protein ligase NEDD4-like isoform X10
E3 ubiquitin-protein ligase NEDD4-like isoform X11
uncharacterized LOC122425709, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 ESTs, and 55% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC122425709, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 ESTs, and 68% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC122425567, transcript variant X2
uncharacterized LOC122425567, transcript variant X4
uncharacterized LOC122425567, transcript variant X1
uncharacterized LOC122425567, transcript variant X5
uncharacterized LOC122425567, transcript variant X3
MALT1 paracaspase, transcript variant X1
MALT1 paracaspase, transcript variant X3
MALT1 paracaspase, transcript variant X2
mucosa-associated lymphoid tissue lymphoma translocation protein 1 isoform X1
mucosa-associated lymphoid tissue lymphoma translocation protein 1 isoform X3
mucosa-associated lymphoid tissue lymphoma translocation protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
cytochrome c oxidase subunit 7C, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, and 65% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 532, transcript variant X4
zinc finger protein 532, transcript variant X2
zinc finger protein 532, transcript variant X1
zinc finger protein 532, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
zinc finger protein 532, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
SEC11 homolog C, signal peptidase complex subunit
signal peptidase complex catalytic subunit SEC11C
retina and anterior neural fold homeobox
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 31% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 5 Proteins, and 74% coverage of the annotated genomic feature by RNAseq alignments
collagen and calcium binding EGF domains 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
collagen and calcium-binding EGF domain-containing protein 1
phorbol-12-myristate-13-acetate-induced protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 22% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ring finger protein 152, transcript variant X3
ring finger protein 152, transcript variant X2
ring finger protein 152, transcript variant X1
ring finger protein 152, transcript variant X4
ring finger protein 152, transcript variant X5
ring finger protein 152, transcript variant X8
ring finger protein 152, transcript variant X6
ring finger protein 152, transcript variant X9
ring finger protein 152, transcript variant X7
ring finger protein 152, transcript variant X10
phosphatidylinositol glycan anchor biosynthesis class N, transcript variant X6
GPI ethanolamine phosphate transferase 1 isoform X2
phosphatidylinositol glycan anchor biosynthesis class N, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
phosphatidylinositol glycan anchor biosynthesis class N, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
phosphatidylinositol glycan anchor biosynthesis class N, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
phosphatidylinositol glycan anchor biosynthesis class N, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
phosphatidylinositol glycan anchor biosynthesis class N, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
phosphatidylinositol glycan anchor biosynthesis class N, transcript variant X5
phosphatidylinositol glycan anchor biosynthesis class N, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
GPI ethanolamine phosphate transferase 1 isoform X3
GPI ethanolamine phosphate transferase 1 isoform X1
GPI ethanolamine phosphate transferase 1 isoform X4
RAB11 binding and LisH domain, coiled-coil and HEAT repeat containing, transcript variant X1
RAB11 binding and LisH domain, coiled-coil and HEAT repeat containing, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00049
TNF receptor superfamily member 11a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
TNF receptor superfamily member 11a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 11A isoform X1
tumor necrosis factor receptor superfamily member 11A isoform X2
TNF receptor superfamily member 11a, transcript variant X3
tumor necrosis factor receptor superfamily member 11A isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 6 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
zinc finger CCHC domain-containing protein 2
PH domain and leucine rich repeat protein phosphatase 1, transcript variant X2
PH domain and leucine rich repeat protein phosphatase 1, transcript variant X1
PH domain leucine-rich repeat-containing protein phosphatase 1 isoform X1
PH domain leucine-rich repeat-containing protein phosphatase 1 isoform X2
BCL2 apoptosis regulator, transcript variant X2
BCL2 apoptosis regulator, transcript variant X1
BCL2 apoptosis regulator, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 ESTs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00396
BCL2 apoptosis regulator, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
3-ketodihydrosphingosine reductase, transcript variant X1
3-ketodihydrosphingosine reductase, transcript variant X2
3-ketodihydrosphingosine reductase isoform X2
3-ketodihydrosphingosine reductase isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00012
vacuolar protein sorting-associated protein 4B
serpin family B member 12, transcript variant X1
serpin family B member 12, transcript variant X2
serpin family B member 13, transcript variant X3
serpin family B member 13, transcript variant X1
serpin family B member 13, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
serpin family B member 11, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
serpin family B member 11, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
serpin family B member 11, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
serpin family B member 11, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
serpin family B member 7, transcript variant X6
serpin family B member 7, transcript variant X2
serpin family B member 7, transcript variant X7
serpin family B member 7, transcript variant X3
serpin family B member 7, transcript variant X1
serpin family B member 7, transcript variant X8
serpin family B member 7, transcript variant X4
serpin family B member 7, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 14 ESTs, 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
conserved oligomeric Golgi complex subunit 2-like, transcript variant X2
conserved oligomeric Golgi complex subunit 2-like, transcript variant X3
conserved oligomeric Golgi complex subunit 2-like, transcript variant X1
conserved oligomeric Golgi complex subunit 2-like isoform X1
conserved oligomeric Golgi complex subunit 2-like isoform X3
conserved oligomeric Golgi complex subunit 2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 54% coverage of the annotated genomic feature by RNAseq alignments
par-6 family cell polarity regulator gamma
activity-dependent neuroprotector homeobox protein 2
ribosome binding factor A, transcript variant X4
ribosome binding factor A, transcript variant X3
ribosome binding factor A, transcript variant X2
ribosome binding factor A, transcript variant X1
putative ribosome-binding factor A, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
probable 2-ketogluconate reductase, transcript variant X5
probable 2-ketogluconate reductase, transcript variant X2
probable 2-ketogluconate reductase, transcript variant X4
probable 2-ketogluconate reductase, transcript variant X3
probable 2-ketogluconate reductase, transcript variant X1
probable 2-ketogluconate reductase, transcript variant X6
thioredoxin like 4A, transcript variant X1
thioredoxin like 4A, transcript variant X2
heat shock factor binding protein 1 like 1, transcript variant X5
heat shock factor binding protein 1 like 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 90% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
heat shock factor binding protein 1 like 1, transcript variant X3
heat shock factor binding protein 1 like 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
heat shock factor binding protein 1 like 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
heat shock factor binding protein 1 like 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
heat shock factor-binding protein 1-like protein 1
solute carrier family 66 member 2, transcript variant X2
solute carrier family 66 member 2, transcript variant X4
solute carrier family 66 member 2, transcript variant X1
solute carrier family 66 member 2, transcript variant X3
solute carrier family 66 member 2 isoform X1
solute carrier family 66 member 2 isoform X2
solute carrier family 66 member 2 isoform X3
potassium voltage-gated channel modifier subfamily G member 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
potassium voltage-gated channel modifier subfamily G member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
potassium voltage-gated channel modifier subfamily G member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium voltage-gated channel modifier subfamily G member 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium voltage-gated channel subfamily G member 2 isoform X1
potassium voltage-gated channel subfamily G member 2 isoform X2
potassium voltage-gated channel subfamily G member 2 isoform X3
CTD phosphatase subunit 1, transcript variant X3
CTD phosphatase subunit 1, transcript variant X1
CTD phosphatase subunit 1, transcript variant X2
RNA polymerase II subunit A C-terminal domain phosphatase isoform X1
RNA polymerase II subunit A C-terminal domain phosphatase isoform X2
RNA polymerase II subunit A C-terminal domain phosphatase isoform X3
tigger transposable element-derived protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
nuclear factor of activated T cells 1, transcript variant X1
nuclear factor of activated T cells 1, transcript variant X2
nuclear factor of activated T-cells, cytoplasmic 1 isoform X1
nuclear factor of activated T-cells, cytoplasmic 1 isoform X2
ATPase phospholipid transporting 9B (putative), transcript variant X1
ATPase phospholipid transporting 9B (putative), transcript variant X2
ATPase phospholipid transporting 9B (putative), transcript variant X3
ATPase phospholipid transporting 9B (putative), transcript variant X4
probable phospholipid-transporting ATPase IIB isoform X2
probable phospholipid-transporting ATPase IIB isoform X1
probable phospholipid-transporting ATPase IIB isoform X3
probable phospholipid-transporting ATPase IIB isoform X4
serine/arginine repetitive matrix protein 3-like, transcript variant X1
serine/arginine repetitive matrix protein 3-like, transcript variant X2
serine/arginine repetitive matrix protein 3-like isoform X1
serine/arginine repetitive matrix protein 3-like isoform X2
ubiquitin-conjugating enzyme E2 D3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
ubiquitin-conjugating enzyme E2 D3-like isoform X1
ubiquitin-conjugating enzyme E2 D3-like, transcript variant X2
ubiquitin-conjugating enzyme E2 D3-like isoform X2
galanin receptor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
galanin receptor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
myelin basic protein, transcript variant X3
myelin basic protein, transcript variant X2
myelin basic protein, transcript variant X1
myelin basic protein, transcript variant X4
zinc finger protein 236, transcript variant X3
zinc finger protein 236, transcript variant X2
zinc finger protein 236, transcript variant X1
zinc finger protein 236, transcript variant X4
zinc finger protein 236, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00156
zinc finger protein 516, transcript variant X5
zinc finger protein 516, transcript variant X6
zinc finger protein 516, transcript variant X2
zinc finger protein 516, transcript variant X1
zinc finger protein 516, transcript variant X10
zinc finger protein 516, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger protein 516, transcript variant X9
zinc finger protein 516, transcript variant X7
zinc finger protein 516, transcript variant X4
zinc finger protein 516, transcript variant X3
zinc binding alcohol dehydrogenase domain containing 2, transcript variant X2
zinc binding alcohol dehydrogenase domain containing 2, transcript variant X1
zinc finger protein 407, transcript variant X1
zinc finger protein 407, transcript variant X3
zinc finger protein 407, transcript variant X2
carnosine dipeptidase 1, transcript variant X1
carnosine dipeptidase 1, transcript variant X2
carnosine dipeptidase 2, transcript variant X2
carnosine dipeptidase 2, transcript variant X3
carnosine dipeptidase 2, transcript variant X1
carnosine dipeptidase 2, transcript variant X4
cytosolic non-specific dipeptidase isoform X1
cytosolic non-specific dipeptidase isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 29% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 62% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein C18orf63 homolog
uncharacterized LOC122425611, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC122425611, transcript variant X2
translocase of inner mitochondrial membrane 21
mitochondrial import inner membrane translocase subunit Tim21
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
transfer RNA alanine (anticodon CGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
neuropilin and tolloid like 1, transcript variant X5
neuropilin and tolloid like 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
neuropilin and tolloid like 1, transcript variant X1
neuropilin and tolloid like 1, transcript variant X2
neuropilin and tolloid like 1, transcript variant X4
neuropilin and tolloid like 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
neuropilin and tolloid-like protein 1 isoform X1
neuropilin and tolloid-like protein 1 isoform X2
neuropilin and tolloid-like protein 1 isoform X3
cerebellin 2 precursor, transcript variant X3
cerebellin 2 precursor, transcript variant X2
cerebellin 2 precursor, transcript variant X4
cerebellin 2 precursor, transcript variant X5
cerebellin 2 precursor, transcript variant X6
cerebellin 2 precursor, transcript variant X1
suppressor of cytokine signaling 6, transcript variant X1
suppressor of cytokine signaling 6, transcript variant X3
suppressor of cytokine signaling 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
39S ribosomal protein L15, mitochondrial-like
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
coiled-coil domain containing 102B, transcript variant X4
coiled-coil domain-containing protein 102B isoform X3
coiled-coil domain containing 102B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
coiled-coil domain-containing protein 102B isoform X2
coiled-coil domain containing 102B, transcript variant X1
coiled-coil domain containing 102B, transcript variant X2
coiled-coil domain-containing protein 102B isoform X1
thioredoxin related transmembrane protein 3, transcript variant X1
thioredoxin related transmembrane protein 3, transcript variant X2
protein disulfide-isomerase TMX3 isoform X1
protein disulfide-isomerase TMX3 isoform X2
dermatan sulfate epimerase like, transcript variant X2
dermatan sulfate epimerase like, transcript variant X4
dermatan sulfate epimerase like, transcript variant X5
dermatan sulfate epimerase like, transcript variant X3
dermatan sulfate epimerase like, transcript variant X1
dermatan sulfate epimerase like, transcript variant X6
transfer RNA tyrosine (anticodon GUA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA serine (anticodon GGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC122425873, transcript variant X2
uncharacterized LOC122425873, transcript variant X1
plasminogen activator inhibitor 2-like, transcript variant X1
plasminogen activator inhibitor 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 89% coverage of the annotated genomic feature by RNAseq alignments
phosphatidylinositol 3-kinase catalytic subunit type 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
ankyrin repeat and LEM domain-containing protein 2-like, transcript variant X1
ankyrin repeat and LEM domain-containing protein 2-like isoform X1
ankyrin repeat and LEM domain-containing protein 2-like, transcript variant X3
ankyrin repeat and LEM domain-containing protein 2-like isoform X3
ankyrin repeat and LEM domain-containing protein 2-like, transcript variant X2
ankyrin repeat and LEM domain-containing protein 2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins
CUGBP Elav-like family member 4, transcript variant X1
CUGBP Elav-like family member 4, transcript variant X43
CUGBP Elav-like family member 4, transcript variant X14
CUGBP Elav-like family member 4, transcript variant X4
CUGBP Elav-like family member 4, transcript variant X44
CUGBP Elav-like family member 4, transcript variant X16
CUGBP Elav-like family member 4, transcript variant X6
CUGBP Elav-like family member 4, transcript variant X17
CUGBP Elav-like family member 4, transcript variant X33
CUGBP Elav-like family member 4, transcript variant X8
CUGBP Elav-like family member 4, transcript variant X20
CUGBP Elav-like family member 4, transcript variant X34
CUGBP Elav-like family member 4, transcript variant X5
CUGBP Elav-like family member 4, transcript variant X3
CUGBP Elav-like family member 4, transcript variant X15
CUGBP Elav-like family member 4, transcript variant X7
CUGBP Elav-like family member 4, transcript variant X18
CUGBP Elav-like family member 4, transcript variant X19
CUGBP Elav-like family member 4, transcript variant X21
CUGBP Elav-like family member 4, transcript variant X9
CUGBP Elav-like family member 4, transcript variant X46
CUGBP Elav-like family member 4, transcript variant X26
CUGBP Elav-like family member 4, transcript variant X50
CUGBP Elav-like family member 4, transcript variant X11
CUGBP Elav-like family member 4, transcript variant X29
CUGBP Elav-like family member 4, transcript variant X10
CUGBP Elav-like family member 4, transcript variant X47
CUGBP Elav-like family member 4, transcript variant X25
CUGBP Elav-like family member 4, transcript variant X12
CUGBP Elav-like family member 4, transcript variant X48
CUGBP Elav-like family member 4, transcript variant X27
CUGBP Elav-like family member 4, transcript variant X28
CUGBP Elav-like family member 4, transcript variant X13
CUGBP Elav-like family member 4, transcript variant X30
CUGBP Elav-like family member 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 7 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
CUGBP Elav-like family member 4, transcript variant X41
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 7 ESTs, 1 Protein, and 90% coverage of the annotated genomic feature by RNAseq alignments
CUGBP Elav-like family member 4, transcript variant X42
CUGBP Elav-like family member 4, transcript variant X45
CUGBP Elav-like family member 4, transcript variant X49
CUGBP Elav-like family member 4, transcript variant X22
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 5 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
CUGBP Elav-like family member 4, transcript variant X24
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 5 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
CUGBP Elav-like family member 4, transcript variant X23
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 5 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
CUGBP Elav-like family member 4, transcript variant X31
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 5 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
CUGBP Elav-like family member 4, transcript variant X32
CUGBP Elav-like family member 4 isoform X38
CUGBP Elav-like family member 4 isoform X39
CUGBP Elav-like family member 4 isoform X41
CUGBP Elav-like family member 4 isoform X42
CUGBP Elav-like family member 4 isoform X43
CUGBP Elav-like family member 4 isoform X36
CUGBP Elav-like family member 4 isoform X37
CUGBP Elav-like family member 4 isoform X40
CUGBP Elav-like family member 4 isoform X44
CUGBP Elav-like family member 4 isoform X1
CUGBP Elav-like family member 4 isoform X13
CUGBP Elav-like family member 4 isoform X3
CUGBP Elav-like family member 4 isoform X15
CUGBP Elav-like family member 4 isoform X5
CUGBP Elav-like family member 4 isoform X16
CUGBP Elav-like family member 4 isoform X28
CUGBP Elav-like family member 4 isoform X7
CUGBP Elav-like family member 4 isoform X19
CUGBP Elav-like family member 4 isoform X29
CUGBP Elav-like family member 4 isoform X4
CUGBP Elav-like family member 4 isoform X2
CUGBP Elav-like family member 4 isoform X14
CUGBP Elav-like family member 4 isoform X6
CUGBP Elav-like family member 4 isoform X17
CUGBP Elav-like family member 4 isoform X18
CUGBP Elav-like family member 4 isoform X20
CUGBP Elav-like family member 4 isoform X8
CUGBP Elav-like family member 4 isoform X27
CUGBP Elav-like family member 4 isoform X22
CUGBP Elav-like family member 4 isoform X45
CUGBP Elav-like family member 4 isoform X10
CUGBP Elav-like family member 4 isoform X25
CUGBP Elav-like family member 4 isoform X9
CUGBP Elav-like family member 4 isoform X21
CUGBP Elav-like family member 4 isoform X11
CUGBP Elav-like family member 4 isoform X23
CUGBP Elav-like family member 4 isoform X24
CUGBP Elav-like family member 4 isoform X12
CUGBP Elav-like family member 4 isoform X26
CUGBP Elav-like family member 4, transcript variant X35
CUGBP Elav-like family member 4, transcript variant X36
CUGBP Elav-like family member 4, transcript variant X37
CUGBP Elav-like family member 4, transcript variant X38
CUGBP Elav-like family member 4, transcript variant X40
CUGBP Elav-like family member 4, transcript variant X39
CUGBP Elav-like family member 4 isoform X30
CUGBP Elav-like family member 4 isoform X31
CUGBP Elav-like family member 4 isoform X32
CUGBP Elav-like family member 4 isoform X33
CUGBP Elav-like family member 4 isoform X35
CUGBP Elav-like family member 4 isoform X34
KIAA1328 ortholog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
KIAA1328 ortholog, transcript variant X3
KIAA1328 ortholog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
tubulin polyglutamylase complex subunit 2
formin homology 2 domain containing 3, transcript variant X9
formin homology 2 domain containing 3, transcript variant X2
formin homology 2 domain containing 3, transcript variant X4
formin homology 2 domain containing 3, transcript variant X1
formin homology 2 domain containing 3, transcript variant X7
formin homology 2 domain containing 3, transcript variant X6
formin homology 2 domain containing 3, transcript variant X5
formin homology 2 domain containing 3, transcript variant X3
formin homology 2 domain containing 3, transcript variant X8
FH1/FH2 domain-containing protein 3 isoform X9
FH1/FH2 domain-containing protein 3 isoform X8
FH1/FH2 domain-containing protein 3 isoform X7
FH1/FH2 domain-containing protein 3 isoform X6
FH1/FH2 domain-containing protein 3 isoform X5
FH1/FH2 domain-containing protein 3 isoform X2
FH1/FH2 domain-containing protein 3 isoform X4
FH1/FH2 domain-containing protein 3 isoform X3
FH1/FH2 domain-containing protein 3 isoform X1
elongator acetyltransferase complex subunit 2
regulation of nuclear pre-mRNA domain containing 1A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
regulation of nuclear pre-mRNA domain containing 1A, transcript variant X2
regulation of nuclear pre-mRNA domain containing 1A, transcript variant X3
regulation of nuclear pre-mRNA domain-containing protein 1A isoform X2
regulation of nuclear pre-mRNA domain-containing protein 1A isoform X3
regulation of nuclear pre-mRNA domain-containing protein 1A isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 64% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, and 76% coverage of the annotated genomic feature by RNAseq alignments
polypeptide N-acetylgalactosaminyltransferase 1, transcript variant X2
polypeptide N-acetylgalactosaminyltransferase 1, transcript variant X3
polypeptide N-acetylgalactosaminyltransferase 1, transcript variant X1
polypeptide N-acetylgalactosaminyltransferase 1, transcript variant X4
polypeptide N-acetylgalactosaminyltransferase 1
INO80 complex subunit C, transcript variant X1
INO80 complex subunit C, transcript variant X2
INO80 complex subunit C, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 24, transcript variant X1
zinc finger protein 24, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 3 Proteins, and 62% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 271, transcript variant X2
zinc finger protein 271, transcript variant X1
zinc finger protein 271, transcript variant X4
zinc finger protein 271, transcript variant X3
zinc finger and SCAN domain containing 30, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger and SCAN domain containing 30, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 ESTs, 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
zinc finger and SCAN domain-containing protein 30 isoform X2
zinc finger and SCAN domain-containing protein 30 isoform X1
zinc finger protein 397, transcript variant X2
zinc finger protein 397, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins
microtubule associated protein RP/EB family member 2, transcript variant X3
microtubule associated protein RP/EB family member 2, transcript variant X2
microtubule associated protein RP/EB family member 2, transcript variant X1
microtubule-associated protein RP/EB family member 2 isoform X2
microtubule-associated protein RP/EB family member 2 isoform X1
microtubule-associated protein RP/EB family member 2 isoform X3
dystrobrevin alpha, transcript variant X2
dystrobrevin alpha, transcript variant X3
dystrobrevin alpha, transcript variant X11
dystrobrevin alpha, transcript variant X7
dystrobrevin alpha, transcript variant X10
dystrobrevin alpha, transcript variant X9
dystrobrevin alpha, transcript variant X5
dystrobrevin alpha, transcript variant X6
dystrobrevin alpha, transcript variant X1
dystrobrevin alpha, transcript variant X17
dystrobrevin alpha, transcript variant X14
dystrobrevin alpha, transcript variant X4
dystrobrevin alpha, transcript variant X8
dystrobrevin alpha, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
dystrobrevin alpha, transcript variant X21
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
dystrobrevin alpha, transcript variant X20
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
dystrobrevin alpha, transcript variant X19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
dystrobrevin alpha, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
dystrobrevin alpha, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
dystrobrevin alpha, transcript variant X18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
dystrobrevin alpha, transcript variant X13
dystrobrevin alpha, transcript variant X23
dystrobrevin alpha, transcript variant X24
dystrobrevin alpha, transcript variant X22
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
dystrobrevin alpha, transcript variant X26
dystrobrevin alpha, transcript variant X25
dystrobrevin alpha, transcript variant X28
dystrobrevin alpha, transcript variant X27
nucleolar protein 4, transcript variant X1
nucleolar protein 4, transcript variant X7
nucleolar protein 4, transcript variant X2
nucleolar protein 4, transcript variant X3
nucleolar protein 4, transcript variant X4
nucleolar protein 4, transcript variant X5
nucleolar protein 4, transcript variant X6
ASXL transcriptional regulator 3, transcript variant X4
ASXL transcriptional regulator 3, transcript variant X3
ASXL transcriptional regulator 3, transcript variant X10
ASXL transcriptional regulator 3, transcript variant X8
ASXL transcriptional regulator 3, transcript variant X2
ASXL transcriptional regulator 3, transcript variant X1
ASXL transcriptional regulator 3, transcript variant X5
ASXL transcriptional regulator 3, transcript variant X6
ASXL transcriptional regulator 3, transcript variant X14
ASXL transcriptional regulator 3, transcript variant X7
ASXL transcriptional regulator 3, transcript variant X13
ASXL transcriptional regulator 3, transcript variant X11
ASXL transcriptional regulator 3, transcript variant X9
ASXL transcriptional regulator 3, transcript variant X12
ASXL transcriptional regulator 3, transcript variant X15
ASXL transcriptional regulator 3, transcript variant X16
ASXL transcriptional regulator 3, transcript variant X17
putative Polycomb group protein ASXL3 isoform X4
putative Polycomb group protein ASXL3 isoform X3
putative Polycomb group protein ASXL3 isoform X2
putative Polycomb group protein ASXL3 isoform X1
putative Polycomb group protein ASXL3 isoform X5
putative Polycomb group protein ASXL3 isoform X6
putative Polycomb group protein ASXL3 isoform X7
coiled-coil domain-containing protein 178
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: kelch-like protein 14
GRB2 associated regulator of MAPK1 subtype 1, transcript variant X1
GRB2 associated regulator of MAPK1 subtype 1, transcript variant X2
GRB2 associated regulator of MAPK1 subtype 1, transcript variant X3
GRB2-associated and regulator of MAPK protein 1 isoform X1
GRB2-associated and regulator of MAPK protein 1 isoform X2
GRB2-associated and regulator of MAPK protein 1 isoform X3
GRB2 associated regulator of MAPK1 subtype 1, transcript variant X4
GRB2-associated and regulator of MAPK protein 1 isoform X4
meprin A subunit beta, transcript variant X1
meprin A subunit beta, transcript variant X2
ring finger protein 138, transcript variant X3
ring finger protein 138, transcript variant X2
ring finger protein 138, transcript variant X5
ring finger protein 138, transcript variant X4
ring finger protein 138, transcript variant X1
E3 ubiquitin-protein ligase RNF138 isoform X2
E3 ubiquitin-protein ligase RNF138 isoform X3
E3 ubiquitin-protein ligase RNF138 isoform X1
ring finger protein 125, transcript variant X1
ring finger protein 125, transcript variant X2
trafficking protein particle complex subunit 8, transcript variant X2
trafficking protein particle complex subunit 8, transcript variant X1
trafficking protein particle complex subunit 8 isoform X1
trafficking protein particle complex subunit 8 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 ESTs, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins
succinate dehydrogenase assembly factor 4, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 99% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA arginine (anticodon ACG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
carbohydrate sulfotransferase 9, transcript variant X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00139
carbohydrate sulfotransferase 9 isoform X1
carbohydrate sulfotransferase 9, transcript variant X2
carbohydrate sulfotransferase 9 isoform X2
carbohydrate sulfotransferase 9, transcript variant X3
carbohydrate sulfotransferase 9 isoform X3
potassium channel tetramerization domain containing 1, transcript variant X2
BTB/POZ domain-containing protein KCTD1 isoform X2
potassium channel tetramerization domain containing 1, transcript variant X3
potassium channel tetramerization domain containing 1, transcript variant X1
BTB/POZ domain-containing protein KCTD1 isoform X1
BTB/POZ domain-containing protein KCTD1 isoform X3
TATA-box binding protein associated factor 4b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 12 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
TATA-box binding protein associated factor 4b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transcription initiation factor TFIID subunit 4B isoform X1
transcription initiation factor TFIID subunit 4B isoform X2
SS18 subunit of BAF chromatin remodeling complex, transcript variant X1
SS18 subunit of BAF chromatin remodeling complex, transcript variant X2
SS18 subunit of BAF chromatin remodeling complex, transcript variant X3
SS18 subunit of BAF chromatin remodeling complex, transcript variant X5
SS18 subunit of BAF chromatin remodeling complex, transcript variant X4
SS18 subunit of BAF chromatin remodeling complex, transcript variant X7
SS18 subunit of BAF chromatin remodeling complex, transcript variant X6
zinc finger protein 521, transcript variant X5
zinc finger protein 521, transcript variant X4
zinc finger protein 521, transcript variant X3
zinc finger protein 521, transcript variant X2
zinc finger protein 521, transcript variant X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00015
impact RWD domain protein, transcript variant X2
impact RWD domain protein, transcript variant X1
oxysterol binding protein like 1A, transcript variant X1
oxysterol binding protein like 1A, transcript variant X2
oxysterol-binding protein-related protein 1 isoform X1
oxysterol binding protein like 1A, transcript variant X4
oxysterol binding protein like 1A, transcript variant X6
oxysterol binding protein like 1A, transcript variant X5
oxysterol binding protein like 1A, transcript variant X3
oxysterol-binding protein-related protein 1 isoform X2
calcium binding tyrosine phosphorylation regulated, transcript variant X13
calcium-binding tyrosine phosphorylation-regulated protein isoform X2
calcium binding tyrosine phosphorylation regulated, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
calcium binding tyrosine phosphorylation regulated, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
calcium binding tyrosine phosphorylation regulated, transcript variant X3
calcium binding tyrosine phosphorylation regulated, transcript variant X5
calcium binding tyrosine phosphorylation regulated, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
calcium binding tyrosine phosphorylation regulated, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
calcium binding tyrosine phosphorylation regulated, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
calcium binding tyrosine phosphorylation regulated, transcript variant X10
calcium binding tyrosine phosphorylation regulated, transcript variant X11
calcium binding tyrosine phosphorylation regulated, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
calcium binding tyrosine phosphorylation regulated, transcript variant X8
calcium binding tyrosine phosphorylation regulated, transcript variant X9
calcium-binding tyrosine phosphorylation-regulated protein isoform X1
transfer RNA tryptophan (anticodon CCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
laminin subunit alpha 3, transcript variant X2
laminin subunit alpha 3, transcript variant X1
laminin subunit alpha 3, transcript variant X3
COORDINATES: nucleotide motif:Rfam:12.0:RF01210
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 34% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat domain-containing protein 29
NPC intracellular cholesterol transporter 1
regulator of MON1-CCZ1, transcript variant X1
regulator of MON1-CCZ1, transcript variant X2
regulator of MON1-CCZ1 complex isoform X1
regulator of MON1-CCZ1 complex isoform X2
serine/threonine-protein kinase RIO3 isoform X1
serine/threonine-protein kinase RIO3 isoform X2
transmembrane protein 241, transcript variant X1
transmembrane protein 241, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
transmembrane protein 241, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
transmembrane protein 241, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transmembrane protein 241, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
transmembrane protein 241, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transmembrane protein 241, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transmembrane protein 241, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
transmembrane protein 241, transcript variant X9
transmembrane protein 241, transcript variant X4
transmembrane protein 241, transcript variant X10
Cdk5 and Abl enzyme substrate 1, transcript variant X2
Cdk5 and Abl enzyme substrate 1, transcript variant X1
CDK5 and ABL1 enzyme substrate 1 isoform X2
CDK5 and ABL1 enzyme substrate 1 isoform X1
RB binding protein 8, endonuclease, transcript variant X3
RB binding protein 8, endonuclease, transcript variant X4
RB binding protein 8, endonuclease, transcript variant X1
RB binding protein 8, endonuclease, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00108
GATA binding protein 6, transcript variant X1
GATA binding protein 6, transcript variant X2
GATA binding protein 6, transcript variant X3
translation initiation factor IF-2-like, transcript variant X5
translation initiation factor IF-2-like, transcript variant X7
translation initiation factor IF-2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
translation initiation factor IF-2-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
translation initiation factor IF-2-like, transcript variant X1
translation initiation factor IF-2-like, transcript variant X2
translation initiation factor IF-2-like, transcript variant X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00586
putative 60S ribosomal protein L39-like 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
abhydrolase domain containing 3, phospholipase
small nuclear ribonucleoprotein D1 polypeptide, transcript variant X3
small nuclear ribonucleoprotein D1 polypeptide, transcript variant X1
small nuclear ribonucleoprotein D1 polypeptide, transcript variant X2
small nuclear ribonucleoprotein Sm D1 isoform X1
small nuclear ribonucleoprotein Sm D1 isoform X2
establishment of sister chromatid cohesion N-acetyltransferase 1, transcript variant X1
establishment of sister chromatid cohesion N-acetyltransferase 1, transcript variant X6
establishment of sister chromatid cohesion N-acetyltransferase 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
establishment of sister chromatid cohesion N-acetyltransferase 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
establishment of sister chromatid cohesion N-acetyltransferase 1, transcript variant X2
establishment of sister chromatid cohesion N-acetyltransferase 1, transcript variant X3
establishment of sister chromatid cohesion N-acetyltransferase 1, transcript variant X4
establishment of sister chromatid cohesion N-acetyltransferase 1, transcript variant X5
GREB1 like retinoic acid receptor coactivator
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Rho associated coiled-coil containing protein kinase 1, transcript variant X1
Rho associated coiled-coil containing protein kinase 1, transcript variant X2
rho-associated protein kinase 1 isoform X1
rho-associated protein kinase 1 isoform X2
Rho associated coiled-coil containing protein kinase 1, transcript variant X3
rho-associated protein kinase 1 isoform X3
transfer RNA glycine (anticodon ACC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
ubiquitin specific peptidase 14, transcript variant X2
ubiquitin specific peptidase 14, transcript variant X1
ubiquitin carboxyl-terminal hydrolase 14
uncharacterized LOC122425481, transcript variant X3
uncharacterized LOC122425481, transcript variant X1
uncharacterized LOC122425481, transcript variant X2
transfer RNA arginine (anticodon CCG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
enolase superfamily member 1, transcript variant X1
enolase superfamily member 1, transcript variant X2
mitochondrial enolase superfamily member 1 isoform X1
mitochondrial enolase superfamily member 1 isoform X2
YES proto-oncogene 1, Src family tyrosine kinase, transcript variant X1
YES proto-oncogene 1, Src family tyrosine kinase, transcript variant X2
adenylate cyclase activating polypeptide 1, transcript variant X2
adenylate cyclase activating polypeptide 1, transcript variant X1
pituitary adenylate cyclase-activating polypeptide
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 83% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00493
COORDINATES: nucleotide motif:Rfam:12.0:RF00494
methyltransferase 4, N6-adenosine, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
N(6)-adenine-specific methyltransferase METTL4 isoform X3
methyltransferase 4, N6-adenosine, transcript variant X1
methyltransferase 4, N6-adenosine, transcript variant X2
N(6)-adenine-specific methyltransferase METTL4 isoform X1
N(6)-adenine-specific methyltransferase METTL4 isoform X2
methyltransferase 4, N6-adenosine, transcript variant X4
N(6)-adenine-specific methyltransferase METTL4 isoform X4
transfer RNA lysine (anticodon UUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
structural maintenance of chromosomes flexible hinge domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 14 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
structural maintenance of chromosomes flexible hinge domain containing 1, transcript variant X2
structural maintenance of chromosomes flexible hinge domain-containing protein 1 isoform X1
structural maintenance of chromosomes flexible hinge domain-containing protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 45% coverage of the annotated genomic feature by RNAseq alignments
phosphatidate phosphatase LPIN2 isoform X1
phosphatidate phosphatase LPIN2 isoform X2
myosin regulatory light polypeptide 9, transcript variant X2
myosin regulatory light polypeptide 9, transcript variant X1
myosin regulatory light polypeptide 9 isoform X1
myosin regulatory light polypeptide 9 isoform X2
myosin regulatory light chain 12B, transcript variant X1
myosin regulatory light chain 12B, transcript variant X2
myosin regulatory light chain 12B, transcript variant X3
TGFB induced factor homeobox 1, transcript variant X2
TGFB induced factor homeobox 1, transcript variant X1
DLG associated protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
DLG associated protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
DLG associated protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
DLG associated protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
DLG associated protein 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
DLG associated protein 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
DLG associated protein 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
DLG associated protein 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
disks large-associated protein 1 isoform X1
disks large-associated protein 1 isoform X5
disks large-associated protein 1 isoform X3
disks large-associated protein 1 isoform X7
disks large-associated protein 1 isoform X4
disks large-associated protein 1 isoform X2
disks large-associated protein 1 isoform X6
DLG associated protein 1, transcript variant X9
disks large-associated protein 1 isoform X8
COORDINATES: nucleotide motif:Rfam:12.0:RF01268
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA glycine (anticodon GCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
A-kinase anchor inhibitor 1, transcript variant X1
A-kinase anchor inhibitor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
A-kinase anchor inhibitor 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
A-kinase anchor inhibitor 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
A-kinase anchor inhibitor 1, transcript variant X4
A-kinase anchor inhibitor 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
A-kinase anchor inhibitor 1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
A-kinase anchor inhibitor 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
A-kinase anchor inhibitor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
A-kinase anchor inhibitor 1, transcript variant X6
zinc finger and BTB domain containing 14, transcript variant X1
zinc finger and BTB domain containing 14, transcript variant X2
zinc finger and BTB domain-containing protein 14
splicing factor, arginine/serine-rich 19-like
erythrocyte membrane protein band 4.1 like 3, transcript variant X13
erythrocyte membrane protein band 4.1 like 3, transcript variant X1
erythrocyte membrane protein band 4.1 like 3, transcript variant X5
erythrocyte membrane protein band 4.1 like 3, transcript variant X7
erythrocyte membrane protein band 4.1 like 3, transcript variant X6
erythrocyte membrane protein band 4.1 like 3, transcript variant X24
erythrocyte membrane protein band 4.1 like 3, transcript variant X20
erythrocyte membrane protein band 4.1 like 3, transcript variant X23
erythrocyte membrane protein band 4.1 like 3, transcript variant X18
erythrocyte membrane protein band 4.1 like 3, transcript variant X11
erythrocyte membrane protein band 4.1 like 3, transcript variant X3
erythrocyte membrane protein band 4.1 like 3, transcript variant X22
erythrocyte membrane protein band 4.1 like 3, transcript variant X17
erythrocyte membrane protein band 4.1 like 3, transcript variant X9
erythrocyte membrane protein band 4.1 like 3, transcript variant X2
erythrocyte membrane protein band 4.1 like 3, transcript variant X21
erythrocyte membrane protein band 4.1 like 3, transcript variant X16
erythrocyte membrane protein band 4.1 like 3, transcript variant X4
erythrocyte membrane protein band 4.1 like 3, transcript variant X19
erythrocyte membrane protein band 4.1 like 3, transcript variant X15
erythrocyte membrane protein band 4.1 like 3, transcript variant X12
erythrocyte membrane protein band 4.1 like 3, transcript variant X14
erythrocyte membrane protein band 4.1 like 3, transcript variant X8
erythrocyte membrane protein band 4.1 like 3, transcript variant X10
uncharacterized LOC122425738, transcript variant X1
uncharacterized LOC122425738, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments
Rho GTPase activating protein 28, transcript variant X1
Rho GTPase activating protein 28, transcript variant X3
Rho GTPase activating protein 28, transcript variant X2
Rho GTPase activating protein 28, transcript variant X5
rho GTPase-activating protein 28 isoform X1
rho GTPase-activating protein 28 isoform X3
rho GTPase-activating protein 28 isoform X2
rho GTPase-activating protein 28 isoform X5
uncharacterized LOC122425812, transcript variant X1
uncharacterized protein LOC122425812 isoform X1
uncharacterized LOC122425812, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
uncharacterized protein LOC122425812 isoform X2
uncharacterized LOC122425812, transcript variant X3
uncharacterized protein LOC122425812 isoform X3
Rho GTPase activating protein 28, transcript variant X4
rho GTPase-activating protein 28 isoform X4
COORDINATES: nucleotide motif:Rfam:12.0:RF00056
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
leucine-rich repeat-containing protein 30
protein tyrosine phosphatase receptor type M, transcript variant X4
protein tyrosine phosphatase receptor type M, transcript variant X6
protein tyrosine phosphatase receptor type M, transcript variant X1
protein tyrosine phosphatase receptor type M, transcript variant X2
protein tyrosine phosphatase receptor type M, transcript variant X5
protein tyrosine phosphatase receptor type M, transcript variant X3
receptor-type tyrosine-protein phosphatase mu isoform X1
receptor-type tyrosine-protein phosphatase mu isoform X4
receptor-type tyrosine-protein phosphatase mu isoform X2
receptor-type tyrosine-protein phosphatase mu isoform X5
receptor-type tyrosine-protein phosphatase mu isoform X3
receptor-type tyrosine-protein phosphatase mu isoform X6
microtubule crosslinking factor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
microtubule crosslinking factor 1, transcript variant X5
microtubule crosslinking factor 1, transcript variant X7
microtubule crosslinking factor 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 ESTs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
microtubule crosslinking factor 1, transcript variant X1
microtubule crosslinking factor 1, transcript variant X2
microtubule cross-linking factor 1 isoform X1
microtubule cross-linking factor 1 isoform X5
microtubule cross-linking factor 1 isoform X7
microtubule cross-linking factor 1 isoform X2
microtubule cross-linking factor 1 isoform X3
microtubule cross-linking factor 1 isoform X4
microtubule crosslinking factor 1, transcript variant X6
microtubule cross-linking factor 1 isoform X6
NADH:ubiquinone oxidoreductase core subunit V2
NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial
ankyrin repeat domain 12, transcript variant X1
ankyrin repeat domain 12, transcript variant X2
ankyrin repeat domain 12, transcript variant X3
ankyrin repeat domain-containing protein 12 isoform X1
ankyrin repeat domain-containing protein 12 isoform X2
ankyrin repeat domain-containing protein 12 isoform X3
ankyrin repeat domain 12, transcript variant X4
ankyrin repeat domain-containing protein 12 isoform X4
twisted gastrulation BMP signaling modulator 1, transcript variant X1
twisted gastrulation BMP signaling modulator 1, transcript variant X2
protein phosphatase 4 regulatory subunit 1, transcript variant X3
protein phosphatase 4 regulatory subunit 1, transcript variant X2
protein phosphatase 4 regulatory subunit 1, transcript variant X1
serine/threonine-protein phosphatase 4 regulatory subunit 1 isoform X3
serine/threonine-protein phosphatase 4 regulatory subunit 1 isoform X2
serine/threonine-protein phosphatase 4 regulatory subunit 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
VAMP associated protein A, transcript variant X1
vesicle-associated membrane protein-associated protein A isoform X1
VAMP associated protein A, transcript variant X2
vesicle-associated membrane protein-associated protein A isoform X2
NSF attachment protein gamma, transcript variant X1
NSF attachment protein gamma, transcript variant X2
piezo type mechanosensitive ion channel component 2, transcript variant X3
piezo type mechanosensitive ion channel component 2, transcript variant X2
piezo type mechanosensitive ion channel component 2, transcript variant X4
piezo type mechanosensitive ion channel component 2, transcript variant X1
piezo type mechanosensitive ion channel component 2, transcript variant X5
piezo-type mechanosensitive ion channel component 2 isoform X5
piezo-type mechanosensitive ion channel component 2 isoform X3
piezo-type mechanosensitive ion channel component 2 isoform X2
piezo-type mechanosensitive ion channel component 2 isoform X4
piezo-type mechanosensitive ion channel component 2 isoform X1
piezo type mechanosensitive ion channel component 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 ESTs, 55 Proteins, and 67% coverage of the annotated genomic feature by RNAseq alignments
G protein subunit alpha L, transcript variant X3
guanine nucleotide-binding protein G(olf) subunit alpha isoform X2
G protein subunit alpha L, transcript variant X2
G protein subunit alpha L, transcript variant X1
guanine nucleotide-binding protein G(olf) subunit alpha isoform X1
metallophosphoesterase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
metallophosphoesterase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
metallophosphoesterase 1, transcript variant X1
metallophosphoesterase 1, transcript variant X2
inositol monophosphatase 2, transcript variant X2
inositol monophosphatase 2, transcript variant X1
inositol monophosphatase 2, transcript variant X3
cell death inducing DFFA like effector a
AFG3 like matrix AAA peptidase subunit 2, transcript variant X2
AFG3 like matrix AAA peptidase subunit 2, transcript variant X1
AFG3 like matrix AAA peptidase subunit 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 7 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
RNA guanine-7 methyltransferase, transcript variant X2
RNA guanine-7 methyltransferase, transcript variant X1
RNA guanine-7 methyltransferase, transcript variant X3
family with sequence similarity 210 member A, transcript variant X1
family with sequence similarity 210 member A, transcript variant X2
low density lipoprotein receptor class A domain containing 4
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
LOW QUALITY PROTEIN: low-density lipoprotein receptor class A domain-containing protein 4
centrosomal protein 192, transcript variant X5
centrosomal protein 192, transcript variant X4
centrosomal protein 192, transcript variant X3
centrosomal protein 192, transcript variant X2
centrosomal protein 192, transcript variant X1
centrosomal protein of 192 kDa isoform X5
centrosomal protein of 192 kDa isoform X4
centrosomal protein of 192 kDa isoform X3
centrosomal protein of 192 kDa isoform X2
centrosomal protein of 192 kDa isoform X1
SEH1 like nucleoporin, transcript variant X1
SEH1 like nucleoporin, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00265
protein tyrosine phosphatase non-receptor type 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
protein tyrosine phosphatase non-receptor type 2, transcript variant X2
protein tyrosine phosphatase non-receptor type 2, transcript variant X3
tyrosine-protein phosphatase non-receptor type 2 isoform X3
tyrosine-protein phosphatase non-receptor type 2 isoform X2
tyrosine-protein phosphatase non-receptor type 2 isoform X1
spire type actin nucleation factor 1, transcript variant X1
spire type actin nucleation factor 1, transcript variant X2
PRELI domain containing 3A, transcript variant X2
PRELI domain containing 3A, transcript variant X1
PRELI domain containing 3A, transcript variant X3
PRELI domain containing protein 3A isoform X3
PRELI domain containing protein 3A isoform X2
PRELI domain containing protein 3A isoform X1